论文信息 - Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer. - 字舞流文

Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer.

J. Verweij | G. Stoter | A. Planting | A. Planting

[1] C. Unger,et al. Hexadecylphosphocholine: a new and selective antitumor drug. , 1990, Cancer treatment reviews.

[2] C. Unger,et al. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). , 1988, European journal of cancer & clinical oncology.